Asian biomedical accelerator will cooperate with five major pharma companies

| By | Biotechnologies

Asia’s largest biomedical accelerator, H. Spectrum, announced last weekend that it will collaborate with five major companies on a range of innovative medical technologies during the Trans 2018 digital health conference in Taipei (Taiwan).

Global giants Bayer, Merck, and GE Ventures have come aboard, and will collaborate with H. Spectrum on applications of artificial intelligence, and to explore new opportunities with U.S. tech company NVIDIA, according to Liberty Times.

Taiwan’s H. Spectrum is the largest biomedical startup accelerator in Asia, and strives to foster entrepreneurship through creative advisory. The accelerator recently outlined an international expansion plan, through which it will collaborate with Wisconsin biotech organizations BioForward, Sutter Health, and Lab Central.

H. Spectrum signed the strategic partnership during the Trans 2018 digital health conference, which was organized by H. Spectrum and Foxconn. The conference brought together some of the world’s most influential biomedical, venture capital, and medical companies.

SOURCE: taiwan news
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.